CTOs on the Move

Vermillion

www.vermillion.com

 
Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.vermillion.com
  • 12117 Bee Caves Rd. Building III, Suite 100
    Austin, TX USA 78738
  • Phone: 512.519.0400

Executives

Name Title Contact Details
Fred Ferrara
Chief Information Officer Profile

Similar Companies

St Lawrence Medical Association

St Lawrence Medical Association is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Forrester

Forrester is a Long Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Progressive Medical International

Progressive Medical International is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Associated X-Ray Imaging

Associated X-Ray Imaging Corp. is a Haverhill, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.